Matches in Nanopublications for { ?s ?p "[The most suitable immunohistochemical criterion to identify basal-like breast carcinomas (BLBC), a molecular subgroup of breast cancer associated with poor prognosis, is the triple negative phenotype along with CK5 and/or EGFR immunoreactivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP775092.RA6b_86LirCZvNIJpvReOI2K6f3EcApBCaJCtYAhdkA7I130_assertion description "[The most suitable immunohistochemical criterion to identify basal-like breast carcinomas (BLBC), a molecular subgroup of breast cancer associated with poor prognosis, is the triple negative phenotype along with CK5 and/or EGFR immunoreactivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP775092.RA6b_86LirCZvNIJpvReOI2K6f3EcApBCaJCtYAhdkA7I130_provenance.
- NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_assertion description "[The most suitable immunohistochemical criterion to identify basal-like breast carcinomas (BLBC), a molecular subgroup of breast cancer associated with poor prognosis, is the triple negative phenotype along with CK5 and/or EGFR immunoreactivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP819215.RAKKG8HrNFQaHXG4wPQMN3Oe9IYC-EtlF-vCOF0_opQxk130_provenance.